example, Lang et al. 23 and Hentschel and Lang 17 reported immediate postoperative rates of weakness of 11%-18% and speech impairment of 27%-33%, with a rate of longterm motor deficit of 8%-9%, and long-term speech deficit of 0%-3%. Similarly, Neuloh et al. 28 reported a transient paresis rate of 18%, and a permanent paresis rate of 12%. In the most recent series by Sanai et al., 31 2% of patients had postoperative hemiparesis (in 1% it was permanent), 8% had postoperative facial droop (in 4% it was permanent), and 5% had postoperative dysarthria (in 1% it was permanent). These studies, however, have focused mainly on speech and motor function as assessed by routine neurological examination. Studies have not reported outcomes evaluated using more sensitive neuropsychological tests, and relatively little attention has been paid to higher-level neurocognitive functioning.
The frequency of neurocognitive impairment in patients with brain tumors and the impact of that impairment on functional status and quality of life have become increasingly appreciated in recent years. It has now been demonstrated that neurocognitive impairment is very common in patients with LGGs as well as those with HGGs. 5, 21, 37, 40 Neurocognitive deficits in patients with brain tumors may be related to disease effects, such as infiltration and displacement of functional brain tissue by tumor mass, tumor-related epilepsy, and the sequelae of treatment with surgery, chemotherapy, and radiotherapy. 6 For example, in LGGs it has been estimated that > 90% of patients will have at least some neuropsychological impairments prior to any treatment. 38 Patients with LGG had lower scores on both objective testing and self-reported cognitive functioning than patients with non-CNS malignancy 20 and have demonstrated impairments in executive function, attention, and verbal working memory, 37, 39 with the severity of cognitive impairments correlating with the degree of epilepsy burden. In HGGs, decline over time in information processing speed, psychomotor function, attention, and working memory has been associated with progression of disease, 5 although adverse neurocognitive effects of therapy have also been documented. 15, 26 Sur gical series have found that neurocognitive function worsened in a majority of patients in the immediate postoperative period. In those with LGG, recovery to and sometimes even exceeding preoperative baseline scores has been seen in at least some patients over time, 39 whereas in those with HGGs, neurocognitive functioning generally declines steadily as the disease progresses. 5 The impact, if any, of surgical excision on neurocognitive functioning in patients with insular tumors remains unknown. Removal of the mass effect of the tumor and cytoreduction of malignant tumor cells may have a beneficial effect on the functional activity of surrounding brain areas. However, the majority of LGGs are infiltrative lesions, with normal brain tissue intermingled within the tumor mass. These infiltrated brain areas frequently remain functional. Thus, the surgical excision of potentially functional insular tissue along with the tumor could result in a worsening of neurocognitive functioning, at least in the short term. In 2 separate studies, Duffau and colleagues 10, 12 reported transient postoperative neuropsychological deficits in 5 (42%) of 12 and 7 (17%) of 42 patients who underwent resections for insular LGG. However, specific details regarding what kinds of neuropsychological deficits occurred were not described in either study. In a third small study, Duffau et al. 9 reported transient postoperative "slowness of ideation" after resection of insular LGG in 5 (45%) of 11 patients. Other studies of patients with insular tumors have reported outcomes in terms of general impairments in functional status, without specifying particular neurocognitive domains. In pioneering studies, Yașargil and colleagues 44, 45 reported that 6.7% of those with benign tumors and 10.9% of those with malignant tumors had persistent postoperative deficits that left patients requiring assistance with activities of daily living. Similarly, Vanaclocha et al. 42 reported that 8.7% of patients had deficits that left them "requiring assistance" after surgery for insular gliomas. Zentner et al. 47 also reported nonspecifically on functional status postoperatively in patients with insular gliomas; 13% had decreased KPS scores after surgery.
In this study, we investigated the neurocognitive functioning of patients undergoing surgery for insular tumors to determine if lesions in the insular region are associated with neurocognitive dysfunction, if resection has an impact on neurocognitive status, and if the neurocognitive impact of insular tumors and the surgery thereof is different for patients with insular versus noninsular tumors.
Methods
The Institutional Review Board at The University of Texas M. D. Anderson Cancer Center approved the chart review protocol (RCR07-0150). A waiver of informed consent was granted due to the retrospective nature of the chart review.
Insular Group Selection
Preoperative neurocognitive evaluations were obtained in 60 of 61 consecutive patients undergoing surgery for an insular tumor, performed by the same neurosurgeon at our institution (The University of Texas M. D. Anderson Cancer Center) between 1993 and 2008. Of these patients, those who had a WHO Grade II or III insular glioma and did not have a previous partial resection of the tumor (37 individuals) were included in the study sample. During insular resection, the anesthetic technique used consisted of the so-called Asleep-Awake-Sedated method, which was developed at M. D. Anderson Cancer Center, and in which regional anesthesia and light general anesthesia are administered with the laryngeal mask airway apparatus (LMA, Inc.). Patients were monitored for speech and motor functions by an anesthesiologist who had neuroanesthesia subspecialty training. Additional data regarding age, sex, preoperative KPS score, years of education, presenting symptoms, side and location of the tumor, pathological diagnosis, and tumor volume were prospectively obtained. The patients' degree of education was stratified into 3 levels (≤ 12 years, 13-16 years, and > 16 years). Two patients did not receive postoperative neurocognitive evaluations and were therefore excluded, leaving a final sample size of 35.
Control Group Selection
A list of all patients who underwent resection of a WHO Grade II or III glioma and in whom pre-and postoperative neurocognitive evaluations were performed during the same time period was obtained using the departmental clinical database. Each patient in the insular group was individually matched with a control patient according to the following 5 criteria, listed in order of importance: 1) tumor in the same hemisphere; 2) tumor of the same WHO grade; 3) preoperative KPS score within 10 points; 4) age within 5 years; and 5) same level of education. If more than one potential match fit all 5 criteria, then preference was given to control tumors situated in cortical areas nearest the insula, such as the frontal and temporal opercula, and closest to the insular tumor in volume, in that order of preference.
If no control was available that matched in all 5 criteria, then a difference in age of > 5 years, degree of education within one level, preoperative KPS score of up to 20 points, or a difference in WHO tumor grade was accepted, in that order of preference. Potential controls with tumors in opposite hemispheres or a KPS score difference > 20 points were considered unacceptable matches and were rejected.
After all the aforementioned criteria were considered, 2 insular tumors remained unmatchable and were excluded from further analysis, leaving 33 pairs of matched insular gliomas and control gliomas in noninsular brain for inclusion in this study. Table 1 shows the characteristics of each matched pair. The spatial distribution of the centers of the control tumors in the frontal, temporal, and parietal areas surrounding the insula is shown in Fig. 1 . For each patient, immediate and 3-month surgical outcomes were determined based on standard neurological examinations performed during inpatient and outpatient clinical assessments, as documented in clinical notes obtained from the medical record.
Neuropsychological Evaluation
Formal neuropsychological evaluations were conducted before and after resection. All testing was conducted by a licensed neuropsychologist or a trained, supervised psychometrist. The neuropsychological assessment used a flexible battery approach and generally consisted of tests designed to assess attention, processing speed, executive function, learning and memory, expressive and receptive language, visuoconstruction, and upper-extremity strength and dexterity; the tests that were most frequently used in the assessment of patients with insular tumors are summarized in Table 2 . The selected tests are widely used, standardized psychometric instruments, and have been found to be sensitive to the neurotoxic effects of cancer and cancer treatments. 4, 19, 30, 34, 43 When available, alternate forms were used to minimize practice effects.
Volumetric Analysis
Volumetric analysis in all insular and control cases was performed on pre-and postoperative MR images with MedVision 1.41 software, as previously described. 35 For nonenhancing tumors, T1 hypointensity volume was used to calculate total tumor volume. For primarily enhancing tumors, T1 hyperintensity was used to calculate total tumor volume. Extent of resection was then calculated using the pre-and postoperative tumor volumes.
Statistical Analysis
Raw scores on each measure were converted to standardized scores (z scores; mean = 0, SD = 1) using published normative data that adjust for age, education, sex, ethnicity, and handedness, as appropriate. At baseline, cognitive impairment on any neuropsychological test was defined as a z score ≥ 1.5 SDs below the normative mean. Declines or improvements in neurocognitive test performance following resection were defined a priori by using the RCI, 18 which is derived from the standard error of measurement for each test, by using the following formula: RCI = 1.64(SEdiff), where SEdiff = [2(SEM ]; SEdiff is the standard error of difference, SEM is the standard error of measurement, SD is the standard deviation, and r xy is the test-retest reliability statistic. All RCI thresholds were rounded to the nearest whole number. Changes that did not meet the RCI criteria for decline or improvement were classified as stable.
The Wilcoxon rank-sum test and the Fisher exact test were used to compare patient characteristics between the insular and control groups. The Wilcoxon signed-rank test was used to compare the baseline neurocognitive scores and the changes in the neurocognitive scores after surgery between the 2 groups. The McNemar test was used to compare baseline impairment status and the changes in impairment status after surgery between the insular and control groups. Linear mixed models and generalized estimating equations using logit links were fit to assess the association between neurocognitive scores and various predictors, including the following: postsurgery impairment status, clinical factors, demographic factors, and baseline neurocognitive scores. Statistical analyses were performed using S-plus (TIBCO) and SAS (SAS Institute, Inc.) software.
Results

Patient Characteristics
A summary of clinical, surgical, and tumor characteristics is given in Table 3 . The majority of tumors were on the left side. Insular tumors were most commonly confined within the insula (60%), followed by tumors with temporal extension (21%), then tumors with frontal extension (12%). Two tumors (6%) had both frontal and temporal extension. Control tumors were distributed primarily in the frontal and temporal lobes (54% and 39%, respectively). Frontal tumors were found in the anterior frontal lobe (15%), the frontal operculum (21%), the premotor area (12%), and the primary motor area (6%). Temporal tumors were found in the anterior temporal lobe (6%), mesial temporal area (12%), temporal operculum (9%), lateral temporal lobe (3%), and posterior temporal area (9%). Two tumors were in the parietal lobe, both of which were in the primary sensory area of the parietal operculum. There were no significant differences between the insular and control groups in age, sex ratio, education, preoperative KPS score, histopathological diagnosis, tumor volume, or WHO grade (II vs III), although there was a trend toward more WHO Grade II astrocytomas in the insular group than in the control group (10 vs 3, p = 0.06). Although radical resections were attempted in all insular and control tumor cases, the volumetric extent of resection was greater in the control tumors than in the insular tumors (94.7% vs 83.4%, p = 0.002). The median time to postoperative neurocognitive evaluation in the insular group was 44 days (range 8-205 days), whereas in the control group it was 54 days (range 8-126 days). This difference was not statistically significant (p = 0.16).
Preoperative Test Results
Twenty-four patients (72%) in the insular group and 23 (70%) in the control group presented with seizures. II  100  16  2  24  lt  II  100  16  2  2  39  lt  II  90  12  1  40  lt  II  100  12  1  3  39  lt  II  100  16  2  39  lt  II  100  16  2  4  23  lt  II  90  12  1  21  lt  II  90  12  1  5  48  lt  II  90  16  2  47  lt  II  100 Three patients (9%) in the insular group and 4 (12%) in the control group reported memory deficits. On the preoperative standard neurological examination, 1 patient (3%) in both the insular and control tumor groups had weakness, while 6 patients (18%) in the insular group and 3 (9%) in the control group had speech impairment.
The results of preoperative neurocognitive testing for the insular and control groups are summarized in Fig. 2 . For all tests in all neurocognitive domains, the mean z score (Fig. 2 upper) for the patients in the insular group was within 1 SD of the normative mean. As depicted in Fig. 2 lower, impairment (defined as a z score of ≥ 1.5 SDs below the normative mean) for insular group patients was most often identified in the domains of learning and memory (21% impaired on the HVLT-R), executive functioning (15% impaired on the COWA test), and processing speed (12% impaired on the Trail-Making Test, Part A).
A statistically significant between-group mean difference was seen in visual confrontational naming (Boston Naming Test and Multilingual Aphasia Examination Visual Naming test, Fig. 2 upper) , with patients in the insular group doing worse (-0.3 ± 0.9 in the insular group versus 0.2 ± 0.7 in the control group, with a pairwise mean difference of 0.6 ± 0.2, p = 0.006). Insular group patients were more likely than controls to demonstrate impairment on the COWA test, although this was not statistically significant (p = 0.20). In contrast, patients in the control group were more likely to demonstrate executive dysfunction (Trail-Making Test, Part B); again, this was not a statistically significant difference (p = 0.15). Overall, there were no statistically significant differences in the numbers of patients with baseline impairment (Fig. 2  lower) between the insular and control groups on any test in any domain, with the p values for the comparisons of individual tests ranging from 0.15 to 1.00.
Postoperative Outcomes
In the insular group, 29% of patients had speech deficits and 9% had motor deficits identified on routine neurological examination immediately after surgery. Three months after surgery, the rates of residual impairments were 3% for speech deficits and 6% for motor deficits. In the control group, 24% of patients had speech deficits and 16% had motor deficits identified on routine neurological examination immediately after surgery, and at 3 months postoperatively, the rates of remaining deficits were 8% for speech deficits and 5% for motor deficits. These rates of immediate postoperative and 3-month gross neurological deficits were not statistically significantly different between the insular and control groups.
The mean postoperative z scores for patients in the insular group are depicted in Fig. 3 ; preoperative scores are also provided for comparison. The proportion of patients who improved or declined after resection based on the RCI analysis (as described in Methods) is depicted in Fig.  4 . Overall, there was a tendency for a greater proportion of patients to decline than to improve in their neurocognitive performance on the first assessment after surgery in the domains of learning and memory, executive function, and motor function. In contrast, changes in neurocogni- tive performance were more variable within the domains of language and visuoconstruction, with relatively similar rates of improvement and decline observed on those tests. The McNemar test was used for binary dichotomized pairwise comparisons of both the proportions of declined versus stable/improved and improved versus stable/declined status. There were no statistically significant differences between the insular and control groups with regard to rates of decline on any of the neurocognitive tests, with p values ranging from 0.27 to 1.00. LGGs of unspecified type. ‡ For insular tumors, 60% were purely insular, 21% had temporal extension, 12% had frontal extension, and 6% had both frontal and temporal extension.
Factors Influencing Postoperative Changes in Neurocognitive Performance for Insular Group Patients
To determine what factors affected postoperative changes in neurocognitive performance for patients in the insular group, a linear mixed model adjusted for baseline performance was fitted to assess the impact of preopera- The potential impact of postoperative chemotherapy and radiation on neurocognitive functioning was also examined. Only 4 patients in each group had received chemotherapy prior to their postoperative cognitive assessment. Postoperative radiation was slightly more variable across groups; 4 patients in the insular group and 9 in the control group had received treatment prior to their postoperative cognitive assessment. Across groups, those patients who had received radiation therapy had a significantly longer period of time between their surgery and their postoperative cognitive assessment (mean 110 days vs 34 days). The time between surgery and postoperative cognitive assessment was associated with performance on the HVLT-R and the COWA test, such that patients assessed earlier in the postoperative period evidenced greater decline. After controlling for baseline test performance and time since surgery, radiation was not significantly associated with changes in HVLT-R (F = 2.38, p = 0.13) or COWA (F = 1.48, p = 0.23) scores.
Magnitude of Change in Postoperative Neurocognitive Test Performance
The magnitude of postoperative changes in standardized neurocognitive test performance between the paired insular and control patients was compared by fitting linear mixed models with adjustment for baseline scores. Table 2 for definitions of abbreviations for test names. The mean change in standardized test scores after surgery is shown in Fig. 5 . In all tests, the difference in magnitude of change between insular and control groups was < 0.5 SD, and there were no statistically significant differences in the magnitude of change between the insular and control groups on any test. Effect sizes ranged from 0.01 to 1.44, with the largest effect sizes observed for learning and memory (Cohen's d = 1.08) and right-handed grip strength (Cohen's d = 1.44).
Discussion
This study is the first detailed analysis of neurocognitive function in patients undergoing resection of insular gliomas. Preoperatively, patients with insular tumors were most likely to exhibit impairments in learning and memory; this was also true for control patients. There was a statistically significant difference in the mean standardized score on tests of naming, with patients in the insular group exhibiting greater dysnomia than controls. The observed preoperative difference on expressive language tests is consistent with evidence linking the posterior insula in the dominant hemisphere to language function. 3, 28 Specifically, the insula may be part of a neural circuit (along with the supramarginal gyrus and the Broca area) that is important in the retrieval of phonological information, and may also have a role (along with the primary motor, somatosensory, supplementary and presupplementary motor areas, and the Broca area) in phonetic planning and motor articulation of speech. 14 After adjusting for baseline performance, the factor with the greatest impact on mean standardized change scores in insular tumors was the side of the lesion, with patients harboring right-sided tumors evidencing greater postoperative decline in the domains of visuoconstruction, and patients with left-sided tumors exhibiting greater postoperative decline on tests assessing learning and memory as well as those assessing lexical fluency. The observed association between postoperative decline in these domains and tumor side is not surprising, and is consistent with the known relative functional specialization of the left and right hemispheres. Time between surgery and postoperative assessment did impact performance on these same tests, such that patients evaluated more acutely demonstrat- ed greater declines than those who were evaluated after more time had elapsed. Although there was no statistically significant difference between groups with regard to time between surgery and postoperative cognitive assessment, there was a trend for patients in the insular tumor group to be seen somewhat sooner after surgery; thus, interpretation of between-group differences on tests known to be impacted by time (that is, HVLT-R, COWA) should be made with caution. After controlling for time since surgery, postoperative radiation did not appear to have a significant impact on change in cognitive test scores in the small number of patients who received this treatment.
Postoperatively, we found no statistically significant evidence that the insula is preferentially vulnerable to neurocognitive decline after glioma surgery compared with nearby cortical brain regions. Both patient groups demonstrated the greatest declines (as determined using the RCI) in learning and memory, executive functioning, and motor functioning. There were no statistically significant group differences in mean standardized change scores after adjusting for baseline performance. However, there was a trend toward a greater magnitude of postoperative decline in mean standardized scores for patients in the insular group, which was most evident in learning and memory.
The circuitry and cytoarchitecture of the insular cortex suggest that the insula plays important roles in multiple aspects of higher cognitive functioning. The insula has connections to and from multiple brain areas, including the following: premotor cortex and supplementary motor areas; prefrontal cortex; somatosensory areas of the parietal lobe; limbic areas including anterior cingulate gyrus, amygdala, and entorhinal cortex; hippocampus and piriform cortex in the temporal lobe; other temporal lobe areas; olfactory cortex; and deep connections to the thalamus and basal ganglia. 3 The insula has been associated with many somatic functions, including visceral sensation, tactile recognition, feeding, and autonomic regulation as well as higher-order cognitive and emotional functions, including selective visual attention, verbal working memory, neglect, motor association, 3 processing negative emotions and frustration, 1, 13, 36 recognition of the intentions and emotional states of others, 2, 7 responding to adverse social interactions, 48 assessing unfair economic offers, 32 the development of trust, 25 and mediation of conscious urges in relation to smoking addiction, 27 which is potentially related to a more general function in the anticipation of bodily effects of emotional events. 8 These higher-level functions all involve the integration of multiple inputs from disparate brain areas subserving memory, language, motor functions, emotion, social cognition, and primary sensory modalities, which is consistent with the conception of the insula as a relay center between disparate neocortical and allocortical areas, 3, 41 and its cytoarchitectural identification as a transition zone between neocortex and allocortex. 3 The insular region has been described as an integrator of multimodal input from surrounding brain areas. The absence of statistically significant differences between insular and control patients may thus reflect the consequences of the insular and control tumors disrupting different areas within the same widely distributed neural networks underlying these higher-order neurocognitive functions. Alternatively, given the trends toward adverse impact in different cognitive domains for insular compared with control patients, the lack of statistically significant differences may be due to power issues associated with small sample sizes.
In this study, the insular tumors had a lower average extent of resection than the control tumors, although radical resections were attempted in all cases, probably reflecting the greater technical and anatomical challenges associated with surgery in the insular region. There were also 4 patients with insular WHO Grade II gliomas who were matched with control patients with WHO Grade III gliomas, and patients with HGGs have been reported to have a worse neuropsychological prognosis than patients with LGGs, at least in some circumstances. 46 However, the overall difference in proportions of WHO Grade II and III gliomas between the control and insular groups in this study was not statistically significant. Furthermore, we found no postoperative differences between WHO Grade II and III gliomas on any test in terms of mean change in the standardized score after adjusting for baseline performance. The differences in outcome between low-grade and malignant gliomas reported in the literature may be magnified by the inclusion of glioblastomas in the malignant glioma groups in those studies.
Previous studies of surgery-related morbidity in both gliomas near eloquent brain areas in general, 11, 16, 24, 33 and insular tumors specifically, 23, 29, 31, 42, 45 have focused on speech and gross motor function as measured by neurological examinations. Although mild and transitory immediate deficits remain relatively common, advances in surgical technique and operative adjuncts have substantially reduced the rates of long-term morbidity in patients with tumors in these areas. In our study, the observed rates of surgery-related morbidity as measured by neurological examination were consistent with prior reports in the literature.
Until recently, deficits in higher-order neurocognitive functions after resection had not been closely investigated, and we now find that they are, in fact, quite common. 5, 37, 39 Available data suggest that recovery of neurocognitive functioning over time may be in part related to tumor grade; patients with HGGs tend to worsen, 5 whereas patients with LGGs tend to improve. 39 We did not investigate long-term recovery in this study, and the nature of longterm neurocognitive outcomes in patients undergoing surgery for insular gliomas remains to be determined.
Conclusions
Ultimately, the treatment of insular gliomas should be approached as no different from the treatment of any other glioma situated in or near eloquent brain. Certainly the insular region presents the surgeon with specific anatomical and technical challenges with respect to a safe approach to and resection of a tumor within it, but this is a truism that applies equally to any other tumor in any other region of the brain. The goals of surgical treatment remain the same-maximal safe resection for cytoreduction, relief of symptoms from mass effect, extirpation of epileptogenic foci where present, and accurate tissue diagnosis for prognostic information and planning of potential adjuvant therapies. The same microsurgical techniques are used and the same operative adjuncts are available to aid the surgeon in achieving these therapeutic goals, regardless of whether the tumor in question is found within the insula or elsewhere in the brain.
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